Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artemisia annua extract + rice grain extract is a combination product consisting of two plant-derived ingredients. Artemisia annua, also known as sweet wormwood, is a medicinal plant whose primary active compound, artemisinin, has been widely used for its potent antimalarial properties. Artemisinin and its derivatives are the basis for artemisinin-based combination therapies (ACTs), which are the most effective treatments currently available for drug-resistant malaria[1][2][4]. In addition to antimalarial activity, extracts from Artemisia annua may have other traditional uses and potential anti-inflammatory or antiparasitic effects[4]. Rice grain extract is less well characterized in pharmaceutical contexts but may be included as a carrier or to provide additional nutritional or functional benefits. The specific mechanism of action for this combination depends primarily on the presence of artemisinin from Artemisia annua, which acts rapidly against malaria parasites by generating reactive oxygen species that damage parasite proteins and membranes[1][2]. The role of rice grain extract in this combination is not clearly defined in current scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artemisia annua extract + rice grain extract.